Canagliflozin, a sodium glucose co-transporter 2 inhibitor, reduces post-meal glucose excursion in patients with type 2 diabetes by a non-renal mechanism: results of a randomized trial
| Autor: | Stein, Peter, Berg, Jolene K., Morrow, Linda, Polidori, David, Artis, Eunice, Rusch, Sarah, Vaccaro, Nicole, Devineni, Damayanthi |
|---|---|
| Zdroj: | In Metabolism October 2014 63(10):1296-1303 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect